|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US4263428A
(en)
|
1978-03-24 |
1981-04-21 |
The Regents Of The University Of California |
Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
|
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4338397A
(en)
*
|
1980-04-11 |
1982-07-06 |
President And Fellows Of Harvard College |
Mature protein synthesis
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
US4474893A
(en)
|
1981-07-01 |
1984-10-02 |
The University of Texas System Cancer Center |
Recombinant monoclonal antibodies
|
|
DE3374837D1
(en)
|
1982-02-17 |
1988-01-21 |
Ciba Geigy Ag |
Lipids in the aqueous phase
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4755465A
(en)
*
|
1983-04-25 |
1988-07-05 |
Genentech, Inc. |
Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
|
|
US4710457A
(en)
*
|
1983-06-29 |
1987-12-01 |
Sloan-Kettering Institute For Cancer Research |
Monoclonal antibody for human hematopoietic glycoproteins and method
|
|
HUT35524A
(en)
|
1983-08-02 |
1985-07-29 |
Hoechst Ag |
Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
|
|
EP0143949B1
(en)
|
1983-11-01 |
1988-10-12 |
TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION |
Pharmaceutical composition containing urokinase
|
|
US4740461A
(en)
|
1983-12-27 |
1988-04-26 |
Genetics Institute, Inc. |
Vectors and methods for transformation of eucaryotic cells
|
|
EP0154316B1
(en)
|
1984-03-06 |
1989-09-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified lymphokine and production thereof
|
|
WO1986000922A1
(en)
|
1984-07-30 |
1986-02-13 |
The Salk Institute For Biological Studies |
Retroviral gene transfer vectors
|
|
US4699880A
(en)
|
1984-09-25 |
1987-10-13 |
Immunomedics, Inc. |
Method of producing monoclonal anti-idiotype antibody
|
|
US5900400A
(en)
|
1984-12-06 |
1999-05-04 |
Amgen Inc. |
Serine protease inhibitor analogs
|
|
US4760130A
(en)
|
1984-12-06 |
1988-07-26 |
Synergen Biologicals, Inc. |
Serine protease inhibitors and methods for isolation of same
|
|
JPS6291197A
(ja)
|
1985-10-17 |
1987-04-25 |
Dainippon Pharmaceut Co Ltd |
抗ヒトインタ−ロイキン１抗体，その製法及びその使用法
|
|
US6410516B1
(en)
|
1986-01-09 |
2002-06-25 |
President & Fellows Of Harvard College |
Nuclear factors associated with transcriptional regulation
|
|
US4959455A
(en)
|
1986-07-14 |
1990-09-25 |
Genetics Institute, Inc. |
Primate hematopoietic growth factors IL-3 and pharmaceutical compositions
|
|
US4935343A
(en)
|
1986-08-08 |
1990-06-19 |
Syntex (U.S.A.) Inc. |
Monoclonal antibodies for interleukin-1β
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
DE3785186T2
(de)
|
1986-09-02 |
1993-07-15 |
Enzon Lab Inc |
Bindungsmolekuele mit einzelpolypeptidkette.
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
DK590387A
(da)
|
1986-11-13 |
1988-05-14 |
Otsuka Pharma Co Ltd |
Antistoffer mod interleukin-1
|
|
US4912040A
(en)
|
1986-11-14 |
1990-03-27 |
Genetics Institute, Inc. |
Eucaryotic expression system
|
|
US5359032A
(en)
|
1987-08-26 |
1994-10-25 |
Biogen Inc. |
Interkeukin-1 inhibitor
|
|
US5512544A
(en)
|
1987-09-13 |
1996-04-30 |
Yeda Research And Development Co. Ltd. |
Pharmaceutical compositions comprising an anticytokine
|
|
IL83878A
(en)
|
1987-09-13 |
1995-07-31 |
Yeda Res & Dev |
Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
|
|
IL98078A0
(en)
|
1991-05-07 |
1992-06-21 |
Yeda Res & Dev |
Pharmaceutical compositions comprising an anticytokyne
|
|
US4892538A
(en)
|
1987-11-17 |
1990-01-09 |
Brown University Research Foundation |
In vivo delivery of neurotransmitters by implanted, encapsulated cells
|
|
US5106627A
(en)
|
1987-11-17 |
1992-04-21 |
Brown University Research Foundation |
Neurological therapy devices
|
|
US5158881A
(en)
|
1987-11-17 |
1992-10-27 |
Brown University Research Foundation |
Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
|
|
WO1989004838A1
(en)
|
1987-11-25 |
1989-06-01 |
Immunex Corporation |
Interleukin-1 receptors
|
|
US4968607A
(en)
|
1987-11-25 |
1990-11-06 |
Immunex Corporation |
Interleukin-1 receptors
|
|
US5319071A
(en)
|
1987-11-25 |
1994-06-07 |
Immunex Corporation |
Soluble interleukin-1 receptors
|
|
US5846534A
(en)
*
|
1988-02-12 |
1998-12-08 |
British Technology Group Limited |
Antibodies to the antigen campath-1
|
|
US4942184A
(en)
*
|
1988-03-07 |
1990-07-17 |
The United States Of America As Represented By The Department Of Health And Human Services |
Water soluble, antineoplastic derivatives of taxol
|
|
GB8807803D0
(en)
|
1988-03-31 |
1988-05-05 |
Glaxo Group Ltd |
Biochemical product
|
|
KR970002917B1
(ko)
|
1988-05-27 |
1997-03-12 |
씨네겐 인코포레이티드 |
인터루킨-i 억제제
|
|
US5075222A
(en)
|
1988-05-27 |
1991-12-24 |
Synergen, Inc. |
Interleukin-1 inhibitors
|
|
US5011472A
(en)
|
1988-09-06 |
1991-04-30 |
Brown University Research Foundation |
Implantable delivery system for biological factors
|
|
IL94039A
(en)
|
1989-08-06 |
2006-09-05 |
Yeda Res & Dev |
Antibodies to tbp - 1 and their use
|
|
US5811261A
(en)
|
1988-09-12 |
1998-09-22 |
Yeda Research And Development Co. Ltd. |
Expression of the recombinant tumor necrosis factor binding protein I (TBP-I)
|
|
US5359037A
(en)
|
1988-09-12 |
1994-10-25 |
Yeda Research And Development Co. Ltd. |
Antibodies to TNF binding protein I
|
|
DE68925935T2
(de)
|
1988-10-01 |
1996-08-14 |
Otsuka Pharma Co Ltd |
Antikörper gegen Interleukin-1-beta
|
|
FR2640146B1
(fr)
|
1988-12-08 |
1993-12-24 |
Commissariat A Energie Atomique |
Anticorps monoclonaux anti-interleukines 1(alpha) et 1(beta), leur procede de production et applications desdits anticorps a la detection des interleukines 1(alpha) et 1(beta) et en therapeutique
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
DK0393438T3
(da)
|
1989-04-21 |
2005-05-30 |
Amgen Inc |
TNF-receptor, TNF-bindende proteiner og DNAér, der koder herfor
|
|
DE3922089A1
(de)
|
1989-05-09 |
1990-12-13 |
Basf Ag |
Neue proteine und ihre herstellung
|
|
IL107267A
(en)
|
1993-10-12 |
2009-07-20 |
Yeda Res & Dev |
Ligand to a member of the tnf/ngf receptor family
|
|
CA2017025C
(en)
|
1989-05-18 |
2008-07-22 |
David Wallach |
Tumor necrosis factor binding protein ii, its purification and antibodies thereto
|
|
JP2877509B2
(ja)
|
1989-05-19 |
1999-03-31 |
アムジエン・インコーポレーテツド |
メタロプロテイナーゼ阻害剤
|
|
US5627262A
(en)
|
1989-07-05 |
1997-05-06 |
The Board Of Regents Of The University Of Oklahoma |
Method and composition for the treatment of septic shock
|
|
IL95031A
(en)
|
1989-07-18 |
2007-03-08 |
Amgen Inc |
Method for the production of a human recombinant tumor necrosis factor inhibitor
|
|
AU630497B2
(en)
|
1989-09-05 |
1992-10-29 |
Immunex Corporation |
Tumor necrosis factor-alpha and -beta receptors
|
|
US5395760A
(en)
|
1989-09-05 |
1995-03-07 |
Immunex Corporation |
DNA encoding tumor necrosis factor-α and -β receptors
|
|
DE10399023I2
(de)
|
1989-09-12 |
2006-11-23 |
Ahp Mfg B V |
TFN-bindende Proteine
|
|
JPH03127800A
(ja)
|
1989-10-13 |
1991-05-30 |
Teijin Ltd |
腫瘍壊死因子活性抑制物質
|
|
HUT64582A
(en)
|
1989-11-29 |
1994-01-28 |
Synergen Inc |
Method for producing recombinant human interleukin-1 inhibitor
|
|
DK0433900T3
(da)
|
1989-12-13 |
1996-01-29 |
Yeda Res & Dev |
Ekspression af rekombinant tumornekrosefaktor bindingsprotein I (TBP-I)
|
|
US5136021A
(en)
|
1990-02-27 |
1992-08-04 |
Health Research, Inc. |
TNF-inhibitory protein and a method of production
|
|
AU649245B2
(en)
|
1990-04-02 |
1994-05-19 |
Amgen, Inc. |
Methods for treating interleukin-1 mediated diseases
|
|
US6552170B1
(en)
|
1990-04-06 |
2003-04-22 |
Amgen Inc. |
PEGylation reagents and compounds formed therewith
|
|
US5151510A
(en)
|
1990-04-20 |
1992-09-29 |
Applied Biosystems, Inc. |
Method of synethesizing sulfurized oligonucleotide analogs
|
|
WO1991017184A1
(en)
|
1990-04-27 |
1991-11-14 |
The Upjohn Company |
Modified interleukin-1 inhibitors
|
|
CA2081774A1
(en)
|
1990-05-01 |
1991-11-02 |
John Stephen Haskill |
Interleukin-1 antagonist and uses thereof
|
|
US5872095A
(en)
|
1990-05-01 |
1999-02-16 |
Chiron Corporation |
IL-1 receptor antagonists medicaments
|
|
US5350683A
(en)
|
1990-06-05 |
1994-09-27 |
Immunex Corporation |
DNA encoding type II interleukin-1 receptors
|
|
GB2246569A
(en)
|
1990-06-15 |
1992-02-05 |
Charing Cross Sunley Research |
Tumour necrosis factor - alpha binding protein
|
|
US7253264B1
(en)
|
1990-06-28 |
2007-08-07 |
Sanofi-Arentideutschland GmbH |
Immunoglobulin fusion proteins, their production and use
|
|
DK0464533T3
(da)
|
1990-06-28 |
1999-04-26 |
Gen Hospital Corp |
Fusionsproteiner med immunglobulindele, deres fremstilling og anvendelse
|
|
WO1992001002A1
(en)
|
1990-07-11 |
1992-01-23 |
Teijin Limited |
Tumor necrosis factor activity inhibitor and production thereof
|
|
JPH06500078A
(ja)
|
1990-08-03 |
1994-01-06 |
スミスクライン・ビーチャム・コーポレイション |
Ｔｎｆ抑制剤
|
|
US5840496A
(en)
|
1990-10-09 |
1998-11-24 |
Chiron Corporation |
Method for diagnosing endometrial cancer
|
|
GB9022648D0
(en)
|
1990-10-18 |
1990-11-28 |
Charing Cross Sunley Research |
Polypeptide and its use
|
|
US5858355A
(en)
|
1990-12-20 |
1999-01-12 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
IRAP gene as treatment for arthritis
|
|
NZ314630A
(en)
|
1991-01-17 |
2000-11-24 |
Harvard College |
Use of trans-splicing ribozymes for genetic modification and cell ablation in a host cell
|
|
SG63617A1
(en)
|
1991-01-18 |
1999-03-30 |
Amgen Boulder Inc |
Methods for treating tumar necrosis factor mediated diseases
|
|
US6565841B1
(en)
|
1991-03-15 |
2003-05-20 |
Amgen, Inc. |
Pulmonary administration of granulocyte colony stimulating factor
|
|
ES2199935T3
(es)
|
1991-03-15 |
2004-03-01 |
Amgen Inc. |
Pegilacion de polipeptidos.
|
|
IL99120A0
(en)
|
1991-08-07 |
1992-07-15 |
Yeda Res & Dev |
Multimers of the soluble forms of tnf receptors,their preparation and pharmaceutical compositions containing them
|
|
JP3122139B2
(ja)
|
1991-10-15 |
2001-01-09 |
マラーキー，ミッシェル，エフ． |
後期段階炎症反応の治療用組成物
|
|
US5961974A
(en)
|
1991-10-25 |
1999-10-05 |
Immunex Corporation |
Monoclonal antibodies to CD40 ligand, pharmaceutical composition comprising the same and hybridomas producing the same
|
|
CA2121798C
(en)
|
1991-10-25 |
2007-07-24 |
Richard J. Armitage |
Novel cytokine
|
|
ES2038546B1
(es)
|
1991-11-08 |
1994-02-16 |
Andromaco Lab |
Procedimiento de obtencion de un producto de naturaleza polipeptidica con actividad inhibidora de la hiperproduccion del factor de necrosis tumoral.
|
|
JPH05244982A
(ja)
*
|
1991-12-06 |
1993-09-24 |
Sumitomo Chem Co Ltd |
擬人化ｂ−ｂ１０
|
|
CA2124967C
(en)
|
1991-12-17 |
2008-04-08 |
Nils Lonberg |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
IL104369A0
(en)
|
1992-01-13 |
1993-05-13 |
Smithkline Beecham Corp |
Novel compounds and compositions
|
|
US5470582A
(en)
|
1992-02-07 |
1995-11-28 |
Syntex (U.S.A.) Inc. |
Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles
|
|
CA2112239C
(en)
|
1992-03-04 |
2000-05-09 |
James A. Bianco |
Enantiomeric hydroxylated xanthine compounds
|
|
CA2133326C
(en)
|
1992-03-30 |
2005-03-01 |
Craig A. Smith |
Fusion proteins comprising tumor necrosis factor receptor
|
|
EP0639079B1
(en)
|
1992-04-30 |
2000-01-12 |
Amgen Inc. |
Methods for treating interleukin-1 and tumor necrosis factor mediated diseases
|
|
JPH05312248A
(ja)
|
1992-05-08 |
1993-11-22 |
Nissan Motor Co Ltd |
シフトレバー装置
|
|
DE4219626A1
(de)
|
1992-06-16 |
1993-12-23 |
Wehling Peter Priv Doz Dr Med |
Methode zur Einschleusung therapeutisch relevanter Gene in Körperzellen
|
|
JPH0630788A
(ja)
|
1992-07-16 |
1994-02-08 |
Otsuka Pharmaceut Co Ltd |
ヒトインターロイキン−１に対する組換え抗体
|
|
US5545716A
(en)
|
1992-09-08 |
1996-08-13 |
University Of Florida |
Superantigen agonist and antagonist peptides
|
|
HU219445B
(hu)
|
1992-09-17 |
2001-04-28 |
Amgen Inc. |
Interleukin-1 inhibitorokat tartalmazó, stabil gyógyszerkészítmények és eljárás előállításukra
|
|
JPH06111399A
(ja)
|
1992-09-30 |
1994-04-22 |
Sony Corp |
光磁気記録媒体及びその製造方法
|
|
US5646154A
(en)
|
1992-10-07 |
1997-07-08 |
Sumitomo Pharmaceuticals Co., Ltd. |
Pharmaceutical compositions for inhibiting the formation of tumor necrosis factor
|
|
JP3589665B2
(ja)
|
1992-10-23 |
2004-11-17 |
イミュネックス・コーポレーション |
可溶性オリゴマー蛋白質の調製法
|
|
US5891438A
(en)
|
1992-10-30 |
1999-04-06 |
The Regents Of The University Of California |
Method for stimulating production of variable region gene family restricted antibodies through B-cell superantigen vaccination
|
|
US5866576A
(en)
|
1992-12-16 |
1999-02-02 |
Cell Therapeutics, Inc. |
Epoxide-containing compounds
|
|
DE59407414D1
(de)
|
1993-01-08 |
1999-01-21 |
Hoechst Ag |
Verwendung von Leflunomid zur Hemmung von Tumornekrosefaktor alpha
|
|
DK0614984T4
(da)
|
1993-03-05 |
2010-12-20 |
Bayer Healthcare Llc |
Humane monoklonale anti-TNF-alfa-antistoffer
|
|
JPH08511507A
(ja)
|
1993-03-08 |
1996-12-03 |
ユニバーシティー オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション |
哺乳動物宿主の結合組織を処置するための遺伝子導入
|
|
EP0689449B1
(fr)
|
1993-03-19 |
2002-10-30 |
Vacsyn S.A. |
Compositions pour l'application en therapeutique humaine, caracterisees par l'association d'un muramyl-peptide a une cytokine
|
|
US6326353B1
(en)
|
1993-03-23 |
2001-12-04 |
Sequus Pharmaceuticals, Inc. |
Enhanced circulation effector composition and method
|
|
US5843905A
(en)
|
1993-06-04 |
1998-12-01 |
Vertex Pharmaceuticals, Incorporated |
Peptidic phosphinyloxymethyl ketones as interleukin-1β-converting enzyme inhibitors
|
|
FR2706772A1
(en)
|
1993-06-22 |
1994-12-30 |
Vacsyn Sa |
Prevention and treatment of septic syndrome with an immunosuppressant, in particular cyclosporin.
|
|
US5698579A
(en)
|
1993-07-02 |
1997-12-16 |
Celgene Corporation |
Cyclic amides
|
|
WO1995001997A1
(en)
|
1993-07-09 |
1995-01-19 |
Smithkline Beecham Corporation |
RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN
|
|
JP3775685B2
(ja)
|
1993-07-28 |
2006-05-17 |
ローン−プーラン・ロレ・リミテツド |
Ｐｄｅ▲ｉｖ▼およびｔｎｆ抑制剤としての化合物
|
|
ATE177083T1
(de)
|
1993-11-29 |
1999-03-15 |
Merrell Pharma Inc |
Benzolsulfonyliminderivate als inhibitoren der il-1 wirkung
|
|
CA2138305A1
(en)
|
1993-12-28 |
1995-06-29 |
Naohito Ohashi |
Tumor necrosis factor production inhibitors
|
|
GB9401460D0
(en)
|
1994-01-26 |
1994-03-23 |
Rhone Poulenc Rorer Ltd |
Compositions of matter
|
|
US5608035A
(en)
|
1994-02-02 |
1997-03-04 |
Affymax Technologies N.V. |
Peptides and compounds that bind to the IL-1 receptor
|
|
EP0746557A4
(en)
|
1994-02-18 |
1997-05-02 |
Cell Therapeutics Inc |
INTRACELLULAR SIGNALING MEDIATORS
|
|
EP0749428B1
(en)
|
1994-03-09 |
1998-07-29 |
Pfizer Inc. |
Isoxazoline compounds as inhibitors of tnf release
|
|
US5741667A
(en)
|
1994-05-27 |
1998-04-21 |
Genentech, Inc. |
Tumor necrosis factor receptor-associated factors
|
|
US5708142A
(en)
|
1994-05-27 |
1998-01-13 |
Genentech, Inc. |
Tumor necrosis factor receptor-associated factors
|
|
US5817822A
(en)
|
1994-06-24 |
1998-10-06 |
Novartis Corporation |
Certain alpha-azacycloalkyl substituted arylsulfonamido acetohydroxamic acids
|
|
IL114417A0
(en)
|
1994-07-07 |
1995-10-31 |
Res Dev Foundation |
Tumor necrosis factor receptor-I associated proteins and protein kinase and methods for their use
|
|
US5877180A
(en)
|
1994-07-11 |
1999-03-02 |
University Of Virginia Patent Foundation |
Method for treating inflammatory diseases with A2a adenosine receptor agonists
|
|
DE69519454T2
(de)
|
1994-07-14 |
2001-05-03 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo, Okayama |
Protein, das Interferon-Gamma Herstellung induziert und monoklonaler Antikörper dagegen
|
|
US5641747A
(en)
|
1994-07-25 |
1997-06-24 |
Temple University-Of The Commonwealth System Of Higher Education |
Treatment of osteopetrotic diseases
|
|
US5633227A
(en)
|
1994-09-12 |
1997-05-27 |
Miles, Inc. |
Secretory leukocyte protease inhibitor as an inhibitor of tryptase
|
|
IT1269989B
(it)
|
1994-09-21 |
1997-04-16 |
Dompe Spa |
Antagonisti recettoriali di il-1 ad aumentata attivita' inibitoria
|
|
FI971412A7
(fi)
|
1994-10-05 |
1997-04-04 |
Darwin Discovery Ltd |
Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasie n estäjinä
|
|
US5852173A
(en)
|
1994-10-19 |
1998-12-22 |
Genetics Institute, Inc. |
TNF receptor death ligand proteins and inhibitors of ligand binding
|
|
TW464656B
(en)
|
1994-11-15 |
2001-11-21 |
Hayashibara Biochem Lab |
Interferon-gamma production inducing polypeptide monoclonal antibody, and agent for interferon-gamma susceptive disease
|
|
US5863926A
(en)
|
1994-12-23 |
1999-01-26 |
Smithkline Beecham Corporation |
4,4-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds
|
|
ZA9510826B
(en)
|
1994-12-23 |
1996-06-20 |
Smithkline Beecham Corp |
3,3-(disubstituted)cyclohexan-1-ol monomers and related compounds
|
|
US6323201B1
(en)
|
1994-12-29 |
2001-11-27 |
The Regents Of The University Of California |
Compounds for inhibition of ceramide-mediated signal transduction
|
|
US6429221B1
(en)
|
1994-12-30 |
2002-08-06 |
Celgene Corporation |
Substituted imides
|
|
WO1996021447A1
(en)
|
1995-01-09 |
1996-07-18 |
Otsuka Pharmaceutical Company, Limited |
Use of carbostyril compounds for inhibition of tnf-alpha
|
|
PE64396A1
(es)
|
1995-01-23 |
1997-01-28 |
Hoffmann La Roche |
Proteina accesoria del receptor de la interleucina 1
|
|
IL117175A
(en)
|
1995-02-20 |
2005-11-20 |
Sankyo Co |
Osteoclastogenesis inhibitory factor protein
|
|
US6001349A
(en)
|
1995-02-22 |
1999-12-14 |
Therion Biologics Corporation |
Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof
|
|
ATE191615T1
(de)
|
1995-02-23 |
2000-04-15 |
Novartis Nutrition Ag |
Aminosäurenzusammensetzungen und verwendung derselben klinischen nährung
|
|
WO1996028546A1
(en)
|
1995-03-15 |
1996-09-19 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptor
|
|
EP0737471A3
(fr)
|
1995-04-10 |
2000-12-06 |
L'oreal |
Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue
|
|
CA2218503C
(en)
|
1995-04-20 |
2001-07-24 |
Pfizer Inc. |
Arylsulfonyl hydroxamic acid derivatives
|
|
JPH11507205A
(ja)
|
1995-04-27 |
1999-06-29 |
ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド |
ヒト腫瘍壊死因子受容体
|
|
CA2217850A1
(en)
|
1995-05-10 |
1996-11-14 |
Chirotech Technology Limited |
Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
|
|
AR004471A1
(es)
|
1995-05-31 |
1998-12-16 |
Smithkline Beecham Corp |
Compuestos de ciclohexan-1-ol-4,4-disustituidos, utiles en el tratamiento de enfermedades alergicas e inflamatorias y composiciones farmaceuticas que lascontienen
|
|
US5843901A
(en)
|
1995-06-07 |
1998-12-01 |
Advanced Research & Technology Institute |
LHRH antagonist peptides
|
|
CA2222914C
(en)
|
1995-06-07 |
2002-04-02 |
Immunex Corporation |
Novel cd40l mutein
|
|
US5739143A
(en)
|
1995-06-07 |
1998-04-14 |
Smithkline Beecham Corporation |
Imidazole compounds and compositions
|
|
US5817476A
(en)
|
1995-06-07 |
1998-10-06 |
Genetics Institute, Inc. |
Polynucleotides encoding interleukin-1 receptor intracellular ligand proteins
|
|
US5830742A
(en)
|
1995-06-08 |
1998-11-03 |
Immunex Corporation |
TNF-α converting enzyme
|
|
KR101004174B1
(ko)
|
1995-06-29 |
2010-12-24 |
임뮤넥스 코포레이션 |
세포소멸을 유도하는 시토킨
|
|
US6127977A
(en)
|
1996-11-08 |
2000-10-03 |
Cohen; Nathan |
Microstrip patch antenna with fractal structure
|
|
ZA966663B
(en)
|
1995-08-17 |
1998-02-06 |
Genentech Inc |
Traf Inhibitors.
|
|
US5728844A
(en)
|
1995-08-29 |
1998-03-17 |
Celgene Corporation |
Immunotherapeutic agents
|
|
JPH11511463A
(ja)
|
1995-08-31 |
1999-10-05 |
スミスクライン・ビーチャム・コーポレイション |
インターロイキン変換酵素およびアポプトーシス
|
|
IL115245A
(en)
|
1995-09-11 |
2002-12-01 |
Yissum Res Dev Co |
Tumor necrosis factor inhibiting pharmaceuticals
|
|
AU7169296A
(en)
|
1995-09-27 |
1997-04-17 |
Board Of Trustees Of The Leland Stanford Junior University |
Methods for determining t-cell profiles of immunocompromised subjects
|
|
DK0859784T3
(da)
|
1995-10-05 |
2003-04-22 |
Darwin Discovery Ltd |
Thiosubstituerede peptider som inhibitorer af metalloproteinaser og TNF-frigivelse
|
|
DE19540475A1
(de)
|
1995-10-20 |
1997-04-24 |
Schering Ag |
Chirale Methylphenyloxazolidinone
|
|
US6281352B1
(en)
|
1995-11-14 |
2001-08-28 |
Dupont Pharmaceuticals Company |
Macrocyclic compounds as metalloprotease inhibitors
|
|
SI9620120A
(sl)
|
1995-11-14 |
1999-06-30 |
Dupont Pharmaceuticals Company |
Nove makrociklične spojine kot metaloproteazni inhibitorji
|
|
US6090382A
(en)
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
|
CO4750805A1
(es)
*
|
1995-12-13 |
1999-03-31 |
Sumitomo Chemical Co |
Compuesto para champu
|
|
US5869315A
(en)
|
1995-12-18 |
1999-02-09 |
Basf Aktiengesellschaft |
Modified interleukin-1β converting enzyme with increased stability
|
|
US5990119A
(en)
|
1995-12-21 |
1999-11-23 |
Smithkline Beecham Corporation |
1,4,4-(trisubstituted)cyclohexane monomers and related compounds
|
|
US5869677A
(en)
|
1995-12-21 |
1999-02-09 |
Smithkline Beecham Corporation |
3,3-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds
|
|
US5891883A
(en)
|
1995-12-21 |
1999-04-06 |
Smithkline Beecham Corporation |
4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds
|
|
US6613544B1
(en)
*
|
1995-12-22 |
2003-09-02 |
Amgen Inc. |
Osteoprotegerin
|
|
US6369027B1
(en)
|
1995-12-22 |
2002-04-09 |
Amgen Inc. |
Osteoprotegerin
|
|
CA2238885A1
(en)
|
1995-12-29 |
1997-07-10 |
Incyte Pharmaceuticals, Inc. |
Nucleic acids encoding interferon gamma inducing factor-2
|
|
US6046048A
(en)
|
1996-01-09 |
2000-04-04 |
Genetech, Inc. |
Apo-2 ligand
|
|
DE69739656D1
(de)
|
1996-02-09 |
2009-12-31 |
Amgen Inc |
1 inhibitor und hyaluronan als polymer mit verzögerter wirkstofffreigabe
|
|
DE69721548T2
(de)
|
1996-02-09 |
2004-04-01 |
Abbott Laboratories(Bermuda)Ltd. |
HUMANE ANTIKÖRPER WELCHE AN HUMANEN TNFalpha BINDEN
|
|
US5994351A
(en)
|
1998-07-27 |
1999-11-30 |
Pfizer Inc. |
Arylsulfonylamino hydroxamic acid derivatives
|
|
US5981220A
(en)
|
1996-03-27 |
1999-11-09 |
Human Genome Sciences, Inc. |
Epidermal differentiation factor
|
|
GB9607119D0
(en)
|
1996-04-04 |
1996-06-12 |
Chiroscience Ltd |
Compounds
|
|
GB9607120D0
(en)
|
1996-04-04 |
1996-06-12 |
Chiroscience Ltd |
Compounds
|
|
GB9607249D0
(en)
|
1996-04-04 |
1996-06-12 |
Chiroscience Ltd |
Compounds
|
|
US5710013A
(en)
|
1996-04-19 |
1998-01-20 |
Tularik Inc. |
Tumor necrosis factor receptor associated factor 6 (TRAF6)
|
|
GB9609795D0
(en)
|
1996-05-10 |
1996-07-17 |
Smithkline Beecham Plc |
Novel compounds
|
|
AUPO048296A0
(en)
|
1996-06-14 |
1996-07-11 |
Fujisawa Pharmaceutical Co., Ltd. |
New compound and its preparation
|
|
EP1669454A3
(en)
|
1996-06-27 |
2009-04-01 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
Genomic DNA encoding a polypeptide capable of inducing the production of interferon-gamma
|
|
DE69700616T2
(de)
|
1996-07-02 |
2000-03-16 |
Nisshin Flour Milling Co., Ltd. |
Imid derivate
|
|
TW555765B
(en)
|
1996-07-09 |
2003-10-01 |
Amgen Inc |
Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
|
|
US5853977A
(en)
|
1996-07-12 |
1998-12-29 |
Schering Corporation |
Mammalian TNF-α convertases
|
|
JPH10130149A
(ja)
|
1996-07-12 |
1998-05-19 |
Sankyo Co Ltd |
Ｔｎｆ産生抑制剤
|
|
US5877222A
(en)
|
1996-07-19 |
1999-03-02 |
The Regents Of The University Of California |
Method for treating aids-associated dementia
|
|
GB9616643D0
(en)
|
1996-08-08 |
1996-09-25 |
Chiroscience Ltd |
Compounds
|
|
AU729247B2
(en)
|
1996-08-12 |
2001-01-25 |
Celgene Corporation |
Novel immunotherapeutic agents and their use in the reduction of cytokine levels
|
|
US6069132A
(en)
|
1996-08-14 |
2000-05-30 |
Revanker; Ganapathi R. |
Phosphazole compounds
|
|
CN1169792C
(zh)
|
1996-09-25 |
2004-10-06 |
爱斯制药株式会社 |
取代的乙烯基吡啶衍生物和含有它们的药物
|
|
US5962481A
(en)
|
1996-10-16 |
1999-10-05 |
American Cyanamid Company |
Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
|
|
GB9621859D0
(en)
|
1996-10-21 |
1996-12-11 |
Xenova Ltd |
Cytokine production inhibitors
|
|
GB9712761D0
(en)
|
1997-06-17 |
1997-08-20 |
Chiroscience Ltd |
Quinolines and their therapeutic use
|
|
JPH10147531A
(ja)
|
1996-11-19 |
1998-06-02 |
Otsuka Pharmaceut Co Ltd |
ＴＮＦ−α産生抑制剤
|
|
US5955480A
(en)
|
1996-11-20 |
1999-09-21 |
Merck & Co., Inc. |
Triaryl substituted imidazoles, compositions containing such compounds and methods of use
|
|
EP0948257A4
(en)
|
1996-11-20 |
1999-12-29 |
Merck & Co Inc |
TRIARYL-SUBSTITUTED IMIDAZOLES, COMPOSITIONS CONTAINING THE SAME AND METHOD FOR THEIR USE
|
|
US5834435A
(en)
|
1996-11-27 |
1998-11-10 |
Slesarev; Vladimir I. |
Inhibition of TNF-α pleiotropic and cytotoxic effects
|
|
DE69738539T2
(de)
|
1996-12-03 |
2009-03-26 |
Amgen Fremont Inc. |
Vollkommen humane Antikörper die EGFR binden
|
|
ES2207759T3
(es)
|
1996-12-06 |
2004-06-01 |
Amgen Inc. |
Terapia de combinacion que utiliza una proteina de union del factor de necrosis tumoral (tnf) en el tratamiento de enfermedades inducidas por el tnf.
|
|
DE69738811D1
(de)
|
1996-12-13 |
2008-08-14 |
Schering Corp |
Oberflächenantigene aus Säugern
|
|
DE19652227A1
(de)
|
1996-12-16 |
1998-06-18 |
Bosch Gmbh Robert |
Verfahren und Vorrichtung zum Zuordnen einer Fernbedienung zu einer Basisstation
|
|
JPH10231285A
(ja)
|
1996-12-17 |
1998-09-02 |
Ishihara Sangyo Kaisha Ltd |
フタルイミド誘導体又はその塩、それらの製造方法及びそれらを含有する医薬組成物
|
|
WO1998028423A2
(en)
|
1996-12-20 |
1998-07-02 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use for osteoclast inhibitory factors
|
|
WO1998028424A2
(en)
|
1996-12-23 |
1998-07-02 |
Immunex Corporation |
Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily
|
|
US6271349B1
(en)
|
1996-12-23 |
2001-08-07 |
Immunex Corporation |
Receptor activator of NF-κB
|
|
US7141393B2
(en)
|
1996-12-26 |
2006-11-28 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
Interleukin-18-receptor proteins
|
|
PT853083E
(pt)
|
1997-01-06 |
2001-12-28 |
Pfizer |
Composto de piridilfurano e piridiltiofeno e sua utilizacao farmaceutica
|
|
US5952320A
(en)
|
1997-01-07 |
1999-09-14 |
Abbott Laboratories |
Macrocyclic inhibitors of matrix metalloproteinases and TNFα secretion
|
|
ZA9818B
(en)
|
1997-01-07 |
1998-07-02 |
Abbott Lab |
C-terminal ketone inhibitors of matrix metalloproteinases and tnf alpha secretion
|
|
US6054559A
(en)
|
1997-01-28 |
2000-04-25 |
Smithkline Beecham Corporation |
Interleukin-1 receptor antagonist beta (IL-1raβ)
|
|
AU723895B2
(en)
|
1997-01-29 |
2000-09-07 |
Pfizer Inc. |
Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
|
|
JP3955352B2
(ja)
|
1997-02-25 |
2007-08-08 |
株式会社林原生物化学研究所 |
破骨細胞形成阻害剤
|
|
US5969102A
(en)
|
1997-03-03 |
1999-10-19 |
St. Jude Children's Research Hospital |
Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof
|
|
KR20000075954A
(ko)
|
1997-03-04 |
2000-12-26 |
죤 에이치. 뷰센 |
Ｎ-히드록시 4-술포닐 부탄아미드 화합물
|
|
WO1998039326A1
(en)
|
1997-03-04 |
1998-09-11 |
Monsanto Company |
Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
|
|
WO1998039315A1
(en)
|
1997-03-04 |
1998-09-11 |
Monsanto Company |
Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
|
|
ES2234103T3
(es)
|
1997-03-04 |
2005-06-16 |
Pharmacia Corporation |
Compuestos de acido tioarilsulfonamidohidroxamico.
|
|
WO1998039316A1
(en)
|
1997-03-04 |
1998-09-11 |
Monsanto Company |
N-hydroxy 4-sulfonyl butanamide compounds
|
|
US6087116A
(en)
|
1997-03-12 |
2000-07-11 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
Interleukin-18 (IL-18) receptor polypeptides and their uses
|
|
JPH10259140A
(ja)
|
1997-03-18 |
1998-09-29 |
Sumitomo Pharmaceut Co Ltd |
腫瘍壊死因子産生抑制剤
|
|
SK122199A3
(en)
|
1997-03-18 |
2000-12-11 |
Basf Ag |
Methods and compositions for modulating responsiveness to corticosteroids
|
|
US6054487A
(en)
|
1997-03-18 |
2000-04-25 |
Basf Aktiengesellschaft |
Methods and compositions for modulating responsiveness to corticosteroids
|
|
AU6769298A
(en)
|
1997-03-21 |
1998-10-20 |
Cistron Biotechnology, Inc. |
Method for inhibiting cleavage of precursor il-1beta
|
|
GB9706255D0
(en)
|
1997-03-26 |
1997-05-14 |
Smithkline Beecham Plc |
Novel compounds
|
|
JP2001518090A
(ja)
|
1997-03-28 |
2001-10-09 |
ゼネカ リミテッド |
腫瘍壊死因子の阻害に有用な複素環により置換したヒドロキサム酸
|
|
AU6843498A
(en)
|
1997-03-28 |
1998-10-22 |
Zeneca Limited |
Process for the preparation of n-(3-hydroxy-succinyl)-amino acid derivatives
|
|
WO1998045268A1
(en)
|
1997-04-04 |
1998-10-15 |
Pfizer Products Inc. |
Nicotinamide derivatives
|
|
CN1262625A
(zh)
|
1997-04-10 |
2000-08-09 |
阿吉尼克斯股份有限公司 |
乳铁蛋白在治疗过敏原诱发疾病中的应用
|
|
CA2286290A1
(en)
|
1997-04-15 |
1998-10-22 |
Genetics Institute, Inc. |
Secreted proteins and polynucleotides encoding them
|
|
NZ332995A
(en)
|
1997-04-15 |
2000-07-28 |
Snow Brand Milk Products Co Ltd |
A protein which binds to osteoclastogenesis inhibitory factor (OCIF)
|
|
BR9808545A
(pt)
*
|
1997-04-16 |
2000-05-23 |
Amgen Inc |
ácido nucleico isolado, vetor de expressão, célula hospedeira, processos para produzir uma proteìna de ligação da osteoprotegerina, para detectar a presença de uma proteìna de ligação à osteoprotegerina em uma amostra biológica, para avaliar a capacidade de um composto candidato de ligar-se a uma proteìna de ligação da osteoprotegerina e de um composto de teste para aumentar ou reduzir a ligação da proteìna de ligação da osteoprotegerina a odar, para regular a expressão de uma proteìna de ligação da osteoprotegerina em um animal e para prevenir ou tratar de doença óssea em um mamìfero, polipeptìdeo, protéina de ligação da osteroprotegerina purificada e isolada, ou seu fragmento, análogo ou derivado, e, anticorpo ou seu fragmento
|
|
US5843678A
(en)
*
|
1997-04-16 |
1998-12-01 |
Amgen Inc. |
Osteoprotegerin binding proteins
|
|
US6316408B1
(en)
|
1997-04-16 |
2001-11-13 |
Amgen Inc. |
Methods of use for osetoprotegerin binding protein receptors
|
|
FR2762315B1
(fr)
|
1997-04-22 |
1999-05-28 |
Logeais Labor Jacques |
Derives d'amino-acides inhibiteurs des metalloproteases de la matrice extracellulaire et de la liberation du tnf alpha
|
|
PL191111B1
(pl)
|
1997-04-24 |
2006-03-31 |
Ortho Mcneil Pharm Inc |
Podstawione imidazole, sposób ich wytwarzania, kompozycje zawierające podstawione imidazole oraz ich zastosowanie
|
|
CA2229449A1
(en)
|
1997-04-25 |
1998-10-25 |
Takeda Chemical Industries, Ltd. |
Novel receptor protein and its use
|
|
FR2762514B1
(fr)
|
1997-04-29 |
1999-10-22 |
Sanofi Sa |
Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation
|
|
JP3776203B2
(ja)
|
1997-05-13 |
2006-05-17 |
第一製薬株式会社 |
Ｉｃａｍ−１産生阻害剤
|
|
RU2249591C2
(ru)
|
1997-05-22 |
2005-04-10 |
Дж.Д. Серл Энд Ко. |
3(5)-гетероарилзамещенные пиразолы в качестве ингибиторов киназы p38
|
|
AU7705098A
(en)
|
1997-05-29 |
1998-12-30 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptor-like protein 8
|
|
US6265535B1
(en)
|
1997-05-30 |
2001-07-24 |
The Trustees Of The University Of Pennsylvania |
Peptides and peptide analogues designed from binding sites of tumor necrosis factor receptor superfamily and their uses
|
|
JPH111481A
(ja)
|
1997-06-10 |
1999-01-06 |
Sumitomo Pharmaceut Co Ltd |
ピペリジニルフタラジン誘導体
|
|
SK286940B6
(sk)
|
1997-06-12 |
2009-07-06 |
Aventis Pharma Limited |
Spôsob prípravy imidazolového derivátu
|
|
KR19990001101A
(ko)
|
1997-06-12 |
1999-01-15 |
손경식 |
캐테콜 아미노산 유도체, 이의 제조방법 및 그를 함유한 약제 조성물
|
|
AU7966198A
(en)
|
1997-06-13 |
1998-12-30 |
Smithkline Beecham Corporation |
Novel pyrazole and pyrazoline substituted compounds
|
|
JPH119269A
(ja)
|
1997-06-19 |
1999-01-19 |
Kaken Pharmaceut Co Ltd |
破骨細胞系細胞
|
|
GB9713732D0
(en)
|
1997-06-27 |
1997-09-03 |
Pharmacia & Upjohn Spa |
Substituted triazinic compounds
|
|
GB9713733D0
(en)
|
1997-06-27 |
1997-09-03 |
Pharmacia & Upjohn Spa |
Poly-branched polycarboxamido compounds
|
|
GB9713726D0
(en)
|
1997-06-30 |
1997-09-03 |
Ciba Geigy Ag |
Organic compounds
|
|
US6235787B1
(en)
|
1997-06-30 |
2001-05-22 |
Hoffmann-La Roche Inc. |
Hydrazine derivatives
|
|
EP0994858A1
(en)
|
1997-06-30 |
2000-04-26 |
Ortho-McNeil Pharmaceutical, Inc. |
2-substituted imidazoles useful in the treatment of inflammatory diseases
|
|
WO1999001139A1
(en)
|
1997-07-03 |
1999-01-14 |
Thomas Jefferson University |
An improved method for design and selection of efficacious antisense oligonucleotides
|
|
US5843721A
(en)
|
1997-07-03 |
1998-12-01 |
Tularik Inc. |
Nucleic acids encoding human NIK protein
|
|
WO1999002510A1
(en)
|
1997-07-10 |
1999-01-21 |
Pharmacia & Upjohn S.P.A. |
Matrix metalloproteinase inhibitors
|
|
DE19731521A1
(de)
|
1997-07-23 |
1999-01-28 |
Byk Gulden Lomberg Chem Fab |
Budipin bei der Behandlung entzündlicher Erkrankungen des Nervensystems
|
|
AR016551A1
(es)
|
1997-07-30 |
2001-07-25 |
Smithkline Beecham Corp |
Derivados de 2-oxindol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos
|
|
FR2766822B1
(fr)
|
1997-07-30 |
2001-02-23 |
Adir |
Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
JP2001511448A
(ja)
|
1997-07-31 |
2001-08-14 |
セルジーン コーポレイション |
置換アルカノヒドロキサム酸およびＴＮＦαレベルの減少方法
|
|
JP2001512002A
(ja)
|
1997-08-04 |
2001-08-21 |
ミレニアム ファーマシューティカルズ インク． |
Ｔａｎｇｏ−７７関連蛋白質ファミリーの新規分子およびその使用
|
|
AU8766498A
(en)
|
1997-08-04 |
1999-02-22 |
Amgen, Inc. |
Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors
|
|
CA2268190A1
(en)
|
1997-08-06 |
1999-02-18 |
Suntory Limited |
1-aryl-1,8-naphthylidin-4-one derivative as type iv phosphodiesterase inhibitor
|
|
DK0895988T3
(da)
|
1997-08-08 |
2002-09-09 |
Pfizer Prod Inc |
Arylsulfonylaminohydroxamsyrederivater
|
|
WO1999007679A1
(en)
|
1997-08-08 |
1999-02-18 |
Chiroscience Limited |
Peptidyl compounds having mmp and tnf inhibitory activity
|
|
IL121860A0
(en)
|
1997-08-14 |
1998-02-22 |
Yeda Res & Dev |
Interleukin-18 binding proteins their preparation and use
|
|
US5994396A
(en)
|
1997-08-18 |
1999-11-30 |
Centaur Pharmaceuticals, Inc. |
Furansulfonic acid derivatives and pharmaceutical compositions containing the same
|
|
WO1999009965A2
(en)
|
1997-08-21 |
1999-03-04 |
Takeda Chemical Industries, Ltd. |
Anti-inflammatory agent
|
|
JPH11139994A
(ja)
|
1997-10-31 |
1999-05-25 |
Kureha Chem Ind Co Ltd |
抗腫瘍剤
|
|
CA2308438A1
(en)
|
1997-11-03 |
1999-05-14 |
The Wistar Institute Of Anatomy And Biology |
Method and compositions for inhibiting angiogenesis and treating cancer
|
|
US5955476A
(en)
|
1997-11-18 |
1999-09-21 |
Celgene Corporation |
Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels
|
|
WO1999029865A2
(en)
|
1997-12-12 |
1999-06-17 |
The Rockefeller University |
A protein belonging to the tnf superfamily, nucleic acids encoding same, and methods of use thereof
|
|
EP1047683A1
(en)
|
1998-01-16 |
2000-11-02 |
Centaur Pharmaceuticals, Inc. |
Thioether furan nitrone compounds
|
|
JP2002509153A
(ja)
|
1998-01-20 |
2002-03-26 |
ワーナー−ランバート・カンパニー |
インターロイキン−１β変換酵素（ＩＣＥ）のインビボ阻害剤としてのＮ−［２−（５−ベンジルオキシカルボニル−アミノ−６−オキソ−２−（４−フルオロフェニル）−１，６−ジヒドロ−１−ピリミジニル）アセトキシル］−Ｌ−アスパラギン酸アルデヒド
|
|
PT1047781E
(pt)
|
1998-01-23 |
2004-11-30 |
Immunex Corp |
Receptores de il-18
|
|
NZ505499A
(en)
|
1998-01-23 |
2002-07-26 |
Immunex Corp |
Accessory protein-like DNA and polypeptides
|
|
WO1999037818A1
(en)
|
1998-01-27 |
1999-07-29 |
Millennium Pharmaceuticals, Inc. |
Novel molecules of the tnf receptor superfamily and uses therefor
|
|
BR9907746A
(pt)
|
1998-01-27 |
2000-10-17 |
American Cyanamid Co |
ácidos 2,3,4,5-tetraidro-1h[1,4]-benzodiazepina-3-hidroxâmic os como inibidores de matriz de metaloproteinase
|
|
ES2244178T3
(es)
|
1998-03-09 |
2005-12-01 |
Vertex Pharmaceuticals Incorporated |
Derivados de 1,2-diazepan como inhibidores de la enzima convertidora de interleuquina-1 beta.
|
|
KR20010041905A
(ko)
|
1998-03-16 |
2001-05-25 |
시토비아 인크. |
디펩티드 카스파제 억제제 및 이의 용도
|
|
IL126024A0
(en)
|
1998-03-19 |
1999-05-09 |
Yeda Res & Dev |
Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
|
|
RU2274642C2
(ru)
|
1998-03-19 |
2006-04-20 |
Вертекс Фармасьютикалз Инкорпорейтед |
Ингибиторы каспаз
|
|
HUP0003274A2
(hu)
|
1998-03-20 |
2001-05-28 |
Suntory Limited |
Fenil-metil-benzokinon-származékok, és ezeket a vegyületeket tartalmazó NF-kB inhibitor hatású gyógyszerkészítmények
|
|
JPH11266872A
(ja)
|
1998-03-20 |
1999-10-05 |
Suntory Ltd |
ＮＦ−κＢの活性化を抑制する物質のスクリーニング方法
|
|
WO1999050238A1
(en)
|
1998-03-26 |
1999-10-07 |
Santen Pharmaceutical Co., Ltd. |
Novel urea derivatives
|
|
ATE412746T1
(de)
|
1998-05-14 |
2008-11-15 |
Immunex Corp |
Verfahren zur hemmung der wirkung der osteoklasten
|
|
HUP0102492A2
(hu)
|
1998-06-19 |
2001-11-28 |
Smithkline Beecham Corp. |
Amino-indanon származékok alkalmazása NF-kB transzkripciós faktor inhibitor hatású gyógyszerkészítmények előállítására
|
|
HUP0102782A3
(en)
|
1998-06-19 |
2002-12-28 |
Smithkline Beecham Corp |
Salycilanilide as inhibitors of transcription factor nf-kb
|
|
CA2276216A1
(en)
|
1998-06-24 |
1999-12-24 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
An artificial peptide capable of neutralizing the biological activity of interleukin-18
|
|
US6210924B1
(en)
|
1998-08-11 |
2001-04-03 |
Amgen Inc. |
Overexpressing cyclin D 1 in a eukaryotic cell line
|
|
EP1110969A4
(en)
|
1998-09-01 |
2002-01-09 |
Hayashibara Biochem Lab |
INTERLEUKIN 18-BINDING PROTEINS
|
|
IL141588A0
(en)
|
1998-09-15 |
2002-03-10 |
M & E Biotech As |
Method for down-regulating osteoprotegerin ligand activity
|
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
WO2000037504A2
(en)
|
1998-12-23 |
2000-06-29 |
Pfizer Inc. |
Human monoclonal antibodies to ctla-4
|
|
CA2362126C
(en)
|
1999-02-03 |
2017-01-17 |
Amgen Inc. |
B7rp-1 polypeptides
|
|
WO2000047740A2
(en)
|
1999-02-12 |
2000-08-17 |
Amgen Inc. |
Tnf-related proteins
|
|
AUPQ314799A0
(en)
|
1999-09-29 |
1999-10-21 |
University Of Western Australia, The |
Bone cell factor
|
|
CA2394536A1
(en)
|
1999-12-16 |
2001-06-21 |
Amgen Inc. |
Tnfr/opg-like molecules and uses thereof
|
|
EP1254227A2
(en)
|
2000-02-11 |
2002-11-06 |
Amgen Inc. |
Fusion receptor from tnf family
|
|
WO2001062932A1
(en)
†
|
2000-02-23 |
2001-08-30 |
Amgen Inc. |
Antagonistic selective binding agents of osteoprotegerin binding protein
|
|
US20030103978A1
(en)
|
2000-02-23 |
2003-06-05 |
Amgen Inc. |
Selective binding agents of osteoprotegerin binding protein
|
|
AU2001259432B2
(en)
|
2000-05-03 |
2005-04-21 |
Amgen Inc. |
Modified peptides, comprising an FC domain, as therapeutic agents
|
|
US7102050B1
(en)
|
2000-05-04 |
2006-09-05 |
Exxonmobil Chemical Patents Inc. |
Multiple riser reactor
|
|
US20030215450A1
(en)
*
|
2000-05-26 |
2003-11-20 |
Blake Simon M |
Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
|
|
US7405734B2
(en)
*
|
2000-07-18 |
2008-07-29 |
Silicon Graphics, Inc. |
Method and system for presenting three-dimensional computer graphics images using multiple graphics processing units
|
|
DE10039710B4
(de)
|
2000-08-14 |
2017-06-22 |
United Monolithic Semiconductors Gmbh |
Verfahren zur Herstellung passiver Bauelemente auf einem Halbleitersubstrat
|
|
AU2001286586A1
(en)
*
|
2000-08-18 |
2002-03-04 |
University Of Massachusetts Medical Center |
Trance regulation of chondrocyte differentiation
|
|
WO2002015846A2
(en)
|
2000-08-21 |
2002-02-28 |
Smithkline Beecham Corporation |
Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
|
|
DE60129254T2
(de)
|
2000-09-22 |
2008-03-13 |
Immunex Corp., Thousand Oaks |
Screeningverfahren für agonisten und antagonisten des rezeptoraktivators von nf-kappa b
|
|
AR032028A1
(es)
*
|
2001-01-05 |
2003-10-22 |
Pfizer |
Anticuerpos contra el receptor del factor de crecimiento similar a insulina
|
|
ES2212930T1
(es)
|
2001-05-17 |
2004-08-16 |
Immunex Corporation |
Uso terapeutico de antagonistas de rank.
|
|
EP1432438A2
(en)
|
2001-06-06 |
2004-06-30 |
Immunex Corporation |
Use of rank antagonists to treat cancer
|
|
ES2706902T3
(es)
*
|
2001-06-26 |
2019-04-01 |
Amgen Inc |
Anticuerpos para OPGL
|
|
US7718776B2
(en)
†
|
2002-04-05 |
2010-05-18 |
Amgen Inc. |
Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
|
|
US9401875B2
(en)
|
2012-06-01 |
2016-07-26 |
Nippon Telegraph And Telephone Corporation |
Packet transfer processing method and packet transfer processing device
|
|
US9300829B2
(en)
|
2014-04-04 |
2016-03-29 |
Canon Kabushiki Kaisha |
Image reading apparatus and correction method thereof
|